share_log

PainReform | 6-K/A: Report of foreign private issuer (related to financial reporting)

PainReform | 6-K/A: Report of foreign private issuer (related to financial reporting)

PainReform | 6-K/A:外國發行人報告(業績相關)
美股SEC公告 ·  2024/08/28 14:34

Moomoo AI 已提取核心訊息

PainReform announced its Annual General Meeting of Shareholders to be held on September 30, 2024. Key proposals include re-electing Augustine Lawlor and Dr. Ellen S. Baron as external directors for three-year terms, and approving option grants to directors and executives.The company proposes granting 146,318 options to Chairman and Interim CEO Dr. Ehud Geller, and 22,000 options each to other directors. The options have an exercise price of $0.54 per share. Shareholders will also vote on reappointing Kesselman & Kesselman as the independent auditor for 2024.The meeting will be held at the company's attorneys' offices in Bnei Brak, Israel. Shareholders of record as of September 3, 2024 are eligible to vote. Proxy materials are available on PainReform's website.
PainReform announced its Annual General Meeting of Shareholders to be held on September 30, 2024. Key proposals include re-electing Augustine Lawlor and Dr. Ellen S. Baron as external directors for three-year terms, and approving option grants to directors and executives.The company proposes granting 146,318 options to Chairman and Interim CEO Dr. Ehud Geller, and 22,000 options each to other directors. The options have an exercise price of $0.54 per share. Shareholders will also vote on reappointing Kesselman & Kesselman as the independent auditor for 2024.The meeting will be held at the company's attorneys' offices in Bnei Brak, Israel. Shareholders of record as of September 3, 2024 are eligible to vote. Proxy materials are available on PainReform's website.
PainReform宣佈將於2024年9月30日舉行股東年度大會。主要提案包括重新選舉Augustine Lawlor和Dr. Ellen S. Baron擔任外部董事,任期爲三年,並批准向董事和高管授予期權。公司提議向董事長兼臨時首席執行官Dr. Ehud Geller授予146,318個期權,向其他董事各授予22,000個期權。每股期權的行使價格爲0.54美元。股東還將投票重新任命Kesselman & Kesselman作爲2024年的獨立核數師。會議將於以色列Bnei Brak的公司律師辦公室舉行。截止至2024年9月3日的股東有資格投票。代理材料可在PainReform的網站上獲得。
PainReform宣佈將於2024年9月30日舉行股東年度大會。主要提案包括重新選舉Augustine Lawlor和Dr. Ellen S. Baron擔任外部董事,任期爲三年,並批准向董事和高管授予期權。公司提議向董事長兼臨時首席執行官Dr. Ehud Geller授予146,318個期權,向其他董事各授予22,000個期權。每股期權的行使價格爲0.54美元。股東還將投票重新任命Kesselman & Kesselman作爲2024年的獨立核數師。會議將於以色列Bnei Brak的公司律師辦公室舉行。截止至2024年9月3日的股東有資格投票。代理材料可在PainReform的網站上獲得。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息